" Hypertension is the single most important risk factor for cardiovascular disease and death. Many people don't know they have high blood pressure until they have a stroke ." Zheng Haomin (second from right in the first picture), chief physician of the Center for Evidence-Based Medicine at Rong Zong, pointed out, Hypertension is an important public health problem globally, and the prevalence rate in Taiwan even exceeds 25%. But in fact, cardiovascular disease is predictable and easy to control with timely drug treatment.
"We are currently conducting clinical trials at Rong Zong, Chang Geng, En Zhu Gong, National Taiwan University, and Peking University, with more than 3,000 subjects and more than 100 million pieces of physiological information accumulated." Zhang Shaoyao confidently pointed out that taking heartbeat measurement as an example, FaceHeart Compared with the values measured by clinical medical instruments, the error value of vitals can be maintained within 2 to 3 bpm, which complies with the US FDA SaMD (Software as a Medical Device) certification standard.
➜
Using AI to acquire and retain customers is so easy! Infobip helps brand customers reduce revenue costs and implement precise marketing
"It is expected that the FDA certification for heartbeat ivory coast telegram measurement will be passed as early as next year (2023) at the earliest." Founder Wu Bingfei said, and pointed out that "blood pressure" is the most difficult indicator of all physiological information to achieve high accuracy, but he " We are confident to compete with the European and American markets."
After receiving MediaTek’s Pre-A round of funding in 2019, Juyi Smart’s second tranche of funding has now been announced. What do they want to do next?
Zhang Shaoyao said that he is still actively accumulating users' physiological data to continuously optimize the FaceHeart Vitals software and make the measurement values more accurate.
In addition, "In the European and American markets, we have already negotiated with four customers engaged in telemedicine and medical equipment development. Now we are waiting for the FDA certification to be passed." Zhang Shaoyao shared the commercial value he saw and his future hopes (using AI imaging physiological information Measurement Technology) is investing in the development of more medical hardware, such as continuous blood pressure devices for use in critical care centers, sleep apnea diagnostic tools, and atrial fibrillation detectors.